Caxton Associates (New York)’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $75.6K | Hold |
21,002
| – | – | ﹤0.01% | 470 |
|
|
2024
Q3 | $120K | Hold |
21,002
| – | – | ﹤0.01% | 504 |
|
|
2024
Q2 | $97K | Hold |
21,002
| – | – | ﹤0.01% | 460 |
|
|
2024
Q1 | $172K | Buy |
+21,002
| New | +$172K | 0.01% | 425 |
|
|
2023
Q3 | – | Sell |
-26,721
| Closed | -$73.5K | – | 422 |
|
|
2023
Q2 | $73.5K | Sell |
26,721
-12,204
| -31% | -$33.6K | 0.01% | 466 |
|
|
2023
Q1 | $122K | Buy |
+38,925
| New | +$122K | 0.02% | 449 |
|